These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7949599)

  • 1. Heart rate increases in patients with growth hormone receptor deficiency treated with insulin-like growth factor I.
    Vasconez O; Martinez V; Martinez AL; Hidalgo F; Diamond FB; Rosenbloom AL; Rosenfeld RG; Guevara-Aguirre J
    Acta Paediatr Suppl; 1994 Apr; 399():137-9. PubMed ID: 7949599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
    Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body changes in adolescent patients with growth hormone receptor deficiency receiving recombinant human insulin-like growth factor I and luteinizing hormone-releasing hormone analogue: preliminary results.
    Martinez V; Vasconez O; Martinez AL; Moreno Z; Davila N; Rosenbloom AL; Diamond FB; Bachrach L; Rosenfeld RG; Guevara-Aguirre J
    Acta Paediatr Suppl; 1994 Apr; 399():133-6. PubMed ID: 7949598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency.
    Grahnén A; Kastrup K; Heinrich U; Gourmelen M; Preece MA; Vaccarello MA; Guevara-Aguirre J; Rosenfeld RG; Sietnieks A
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():9-13; discussion 14. PubMed ID: 8219484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Blum WF; Hall K; Ranke MB; Wilton P
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():15-9. PubMed ID: 7693071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.
    Backeljauw PF; Underwood LE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3312-7. PubMed ID: 8784089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.
    Mauras N; Martinez V; Rini A; Guevara-Aguirre J
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3036-42. PubMed ID: 10999782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Wilton P
    Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency.
    Guevara-Aguirre J; Vasconez O; Martinez V; Martinez AL; Rosenbloom AL; Diamond FB; Gargosky SE; Nonoshita L; Rosenfeld RG
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1393-8. PubMed ID: 7536209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a).
    Laron Z; Wang XL; Klinger B; Silbergeld A; Wilcken DE
    Eur J Endocrinol; 1997 Apr; 136(4):377-81. PubMed ID: 9150696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoblot studies of the acid-labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long-term therapy with GH or IGF-I respectively.
    Labarta JI; Gargosky SE; Simpson DM; Lee PD; Argente J; Guevara-Aguirre J; Rosenfeld RG
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):657-66. PubMed ID: 9497872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of insulin-like growth factor (IGF)-I treatment on serum IGFs and IGF binding proteins in adolescent patients with growth hormone receptor deficiency.
    Wilson KF; Fielder PJ; Guevara-Aguirre J; Cohen P; Vasconez O; Martinez V; Martinez A; Rosenbloom AL; Rosenfeld RG
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):399-407. PubMed ID: 7538453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin-like growth factor I treatment on the molecular distribution of insulin-like growth factors among different binding proteins.
    Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Diamond FB; Baxter RC; Rosenbloom AL; Guevara-Aguirre J; Rosenfeld RG
    Acta Paediatr Suppl; 1994 Apr; 399():159-62. PubMed ID: 7524822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of GH, IGF-I and insulin on serum sex hormone binding globulin.
    Gafny M; Silbergeld A; Klinger B; Wasserman M; Laron Z
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):169-75. PubMed ID: 7923821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy with recombinant human insulin-like growth factor I in children with growth hormone receptor insufficiency (Larone's syndrome)].
    Wilton P
    Probl Endokrinol (Mosk); 1994; 40(2):78-82. PubMed ID: 8197102
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I).
    Ranke MB
    Baillieres Clin Endocrinol Metab; 1996 Jul; 10(3):401-10. PubMed ID: 8853447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
    Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum profiles of insulin-like growth factors and their binding proteins in adults with growth hormone receptor deficiency treated with insulin-like growth factor I.
    Fielder PJ; Gargosky SE; Vaccarello M; Wilson K; Cohen P; Diamond F; Guevara-Aguirre J; Rosenbloom AL; Rosenfeld RG
    Acta Paediatr Suppl; 1993 Mar; 388():40-3; discussion 44. PubMed ID: 7687170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.
    Rosenbloom AL; Guevara Aguirre J; Rosenfeld RG; Fielder PJ
    N Engl J Med; 1990 Nov; 323(20):1367-74. PubMed ID: 2233903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.